SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Blomme EAG, Dougherty KM, Pienta KJ, Capen CC, Rosol TJ, McCauley LK 1999 Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein. Prostate 39:187197.
  • 2
    Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW 1998 Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887894.
  • 3
    Shirai T, Tamano S, Takahashi S, Ito N 1992 Animal prostate carcinoma models: Limited potential for vertebral metastases. In: KarrJP, YamanakaH (eds.) Prostate CancerBone Metastasis. Plenum Press, New York, NY, U.S.A., pp. 151158.
  • 4
    Pool RR 1990 Tumors of bonecartilage. In: MoultonJE (ed.) Tumors in Domestic Animals. University of California Press, Berkeley, CA, pp. 157230.
  • 5
    Boorman GA, Wilson JTh, Van Zwieten MJ, Eustis SL 1990 Mammary gl. In: BoormanGA, EustisSL, ElwellMR, MontgomeryCAJr, MacKenzieWF (eds.) Pathology of the Fisher Rat. Academic Press, Inc., San Diego, CA, U.S.A., pp. 295313.
  • 6
    Seely JC, Boorman GA 1999 Mammary glspecialized sebaceous gls. In: MaronpotRR, BoormanGA, GaulBW (eds.) Pathology of the Mouse. Cache River Press, Vienna, IL, U.S.A., pp. 613636.
  • 7
    Moulton JE 1990 Tumors of the mammary gl. In: MoultonJE (ed.) Tumors in Domestic Animals. University of California Press, Berkeley, CA, U.S.A., pp. 518552.
  • 8
    Guise TA, Mundy GR 1998 Cancer and bone. Endocr Rev 19:1854.
  • 9
    Quinn JE, Buhler KR, Brown JM, Bladou E, Lange PH, Vessella RL 1998 A model for prostate cancer bone metastasis: Direct intra-bone injection of prostate cancer xenografts. Bone 23(Suppl):S579.
  • 10
    Parsa M, Murphey MD 1999 Radiographic diagnosismonitoring of bone metastases. In: BodyJ-J (ed.) Tumor Bone DiseasesOsteoporosis in Cancer Patients. Marcel Dekker, Inc., New York, NY, U.S.A., pp. 155195.
  • 11
    Yoneda T, Williams PJ, Myoi A, Michigami T, Mbalaviele G 1999 Cellularmolecular mechanisms of development of skeletal metastases. In: BodyJ-J (ed.) Tumor Bone DiseasesOsteoporosis in Cancer Patients. Marcel Dekker, Inc., New York, NY, U.S.A., pp. 4169.
  • 12
    Mundy GR, Yoneda T 1996 Mechanisms of bone metastasis. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 116.
  • 13
    Rubens RD 1999 Clinical aspects of bone metastases. In: BodyJ-J (ed.) Tumor Bone DiseasesOsteoporosis in Cancer Patients. Marcel Dekker, Inc., New York, NY, U.S.A., pp. 8596.
  • 14
    Henderson MA, Danks JA, Slavin J, Moseley JM, Harris T, Martin TJ 1999 Production of PTHrP by primary breast cancers predicts improved patient survival and decreased bone metastases. J Bone Miner Res 14(Suppl. 1):S153.
  • 15
    Shevrin DH, Kukreja SC 1996 Pathophysiology of human prostate cancer metastasis to bone, studied in vitroin animal models. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 181194.
  • 16
    Resnick MI 1992 Hemodynamics of prostate bone metastases. In: KarrJP, YamanakaH (eds.) Prostate CancerBone Metastasis. Plenum Press, New York, NY, U.S.A., pp. 7781.
  • 17
    Arguello F, Cohen HJ 1996 Structuralmicroenvironmental bone marrow factors involved in the pathogenesis of bone metastasis. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 3146.
  • 18
    Yoneda T 1997 Arterial microvascularization and breast cancer colonization in bone. Histol Histopathol 12:11451149.
  • 19
    Kostenuik PJ, Singh G, Orr FW 1996 Potential role for adhesion in the pathogenesis of bone metastasis. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 5976.
  • 20
    Dougherty KM, Blomme EAG, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK 1999 Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 59:60156022.
  • 21
    Blatch GL, Zetter BR 1996 Bone marrow-derived growth factors for metastatic cancer cells. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 4758.
  • 22
    Sanchez-Sweatman OH, Khokha R, Singh G, Orr FW 1996 Mechanisms of cancer cell-mediated osteolysis. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 123136.
  • 23
    Athanasou NA 1996 Tumor-associated macrophages as mediators of osteolysis in bone metastasis. In: OrrFW, SinghG (eds.) Bone Metastasis—MechanismsPathophysiology. Chapman & Hall, New York, NY, U.S.A., pp. 105122.
  • 24
    Goltzman D, Rabbani SA 1999 Pathogenesis of osteoblastic metastases. In: BodyJ-J (ed.) Tumor Bone DiseasesOsteoporosis in Cancer Patients. Marcel Dekker, Inc., New York, NY, U.S.A., pp. 7184.
  • 25
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309319.
  • 26
    Yin JJ, Grubbs BG, Cui Y, Wu-Wong JR, Wessale J, Padley R, Guise TA 1999 Osteoblastic bone metastases: Tumor-produced endothelin-1 mediates new bone formation via the endothelin A receptor. J Bone Miner Res 14(Suppl. 1):S289.
  • 27
    Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML 1999 Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59:19871993.
  • 28
    Koeneman KS, Yeung F, Chung LW 1999 Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39:246261.
  • 29
    Jacob K, Webber M, Benayahu D, Kleinman HK 1999 Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone. Cancer Res 59:44534457.
  • 30
    Porter PL, Sage EH, Lane TF, Funk SE, Gown AM 1995 Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43:791800.
  • 31
    Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR 1994 Osteopontin expression and distribution in human carcinomas. Am J Pathol 145:610623.
  • 32
    Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA 1999 Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest 79:869877.
  • 33
    Tozawa K, Yamada Y, Kawai N, Okamura T, Ueda K, Kohri K 1999 Osteopontin expression in prostate cancer and benign prostatic hyperplasia. Urol Int 62:155158.
  • 34
    Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509512.
  • 35
    Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF 1995 Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J Cell Biochem 57:680690.
  • 36
    Feng B, Rollo EE, Denhardt DT 1995 Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: Evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin Exp Metastasis 13:453462.
  • 37
    Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M 1999 Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 30:339344.
  • 38
    Colombo MP, Biondi G, Galasso D, Baracetti P, Howe CC, Parmiani G 1989 Osteonectin transcript and metastatic behavior in v-Ki-ras transformed fibroblasts. Int J Cancer Suppl 4:7677.
  • 39
    Bellahcene A, Castronovo V 1997 Expression of bone matrix proteins in human breast cancer: Potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 84:1724.
  • 40
    Bellahcene A, Maloujahmoum N, Fisher LW, Pastorino H, Tagliabue E, Menard S, Castronovo V 1997 Expression of bone sialoprotein in human lung cancer. Calcif Tissue Int 61:183188.
  • 41
    Bellahcene A, Menard S, Bufalino R, Moreau L, Castronovo V 1996 Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer 69:350353.
  • 42
    Bellahcene A, Albert V, Pollina L, Basolo F, Fisher LW, Castronovo V 1998 Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid 8:637641.
  • 43
    Waltregny D, Bellahcene A, Van R, I, Fisher LW, Young M, Fernandez P, Dewe W, de Leval J, Castronovo V 1998 Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 90:10001008.
  • 44
    Bellahcene A, Merville MP, Castronovo V 1994 Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54:28232826.
  • 45
    Sung V, Stubbs JT, III, Fisher L, Aaron AD, Thompson EW 1998 Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 176:482494.
  • 46
    Smit JW, van der Pluijm G, Vloedgraven HJ, Lowik CW, Goslings BM 1998 Role of integrins in the attachment of metastatic follicular thyroid carcinoma cell lines to bone. Thyroid 8:2936.
  • 47
    van der Pluijm G, Vloedgraven HJ, Ivanov B, Robey FA, Grzesik WJ, Robey PG, Papapoulos SE, Lowik CW 1996 Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 56:19481955.
  • 48
    Withold W, Armbruster FP, Karmatschek M, Reinauer H 1997 Bone sialoprotein in serum of patients with malignant bone diseases. Clin Chem 43:8591.
  • 49
    Fedarco NS, Fisher LW 1999 Bone sialoprotein in serum is elevated in osteotropic cancer patient sera. Proceedings of the Second North American Symposium on Skeletal Complications of Malignancy, Montreal, Canada, October 1999, pp. 1417.
  • 50
    Bellahcene A, Kroll M, Liebens F, Castronovo V 1996 Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11:665670.
  • 51
    Lhoták S, Elavathil LJ, Duivenvoorden WCM, Hirte HW, Daya D, Singh G 1999 Osteoclaststumor cells exhibit a different morphology of bone resorption pitsdistinct MMP profiles in bone metastasis of human breast carcinoma. Proceedings of the Second Symposium on Skeletal Metastases, Montreal, October 1999, pp. 1516.
  • 52
    Orr FW, Sanchez-Sweatman OH, Kostenuik P, Singh G 1995 Tumor-bone interactions in skeletal metastasis. Clin Orthop 1933.
  • 53
    Guise TA 1997 Parathyroid hormone-related protein and bone metastases. Cancer 80:15721580.